메뉴 건너뛰기




Volumn 9, Issue 2, 2012, Pages 61-

Prostate cancer: Cardiovascular risk and androgen deprivation therapy

(1)  Razzak, Mina a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; GONADORELIN AGONIST;

EID: 84857033734     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2011.229     Document Type: Note
Times cited : (2)

References (2)
  • 1
    • 80255129259 scopus 로고    scopus 로고
    • Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer
    • doi:10.1016/j.eururo.2011.08.041
    • Azoulay, L. et al. Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer. Eur. Urol. doi:10.1016/j.eururo.2011.08.041
    • Eur. Urol
    • Azoulay, L.1
  • 2
    • 83055163746 scopus 로고    scopus 로고
    • Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer
    • doi:10.1001/jama.2011.1745
    • Nguyen, P. L. et al. Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer. JAMA doi:10.1001/jama. 2011.1745
    • JAMA
    • Nguyen, P.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.